Position in NTLA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$61,437,551
+$24,881,681 QoQ
Shares Held
3,631,061
+27.3% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 330 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. NTLA ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in NTLA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,437,551 | 3,631,061 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $36,555,870 | 2,851,472 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,238,720 | 2,696,187 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $44,709,507 | 2,588,854 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $24,446,361 | 2,606,222 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $17,634,029 | 2,480,173 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $27,858,537 | 2,389,240 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $48,155,019 | 2,343,310 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $51,338,443 | 2,293,943 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $56,237,510 | 2,044,257 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $60,164,971 | 1,973,269 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $59,453,346 | 1,880,245 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $72,830,918 | 1,785,947 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $61,696,422 | 1,655,391 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $55,539,541 | 1,591,847 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $76,896,202 | 1,374,128 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,904,354 | 1,292,588 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $89,153,300 | 1,226,824 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $145,729,854 | 1,232,492 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $160,589,623 | 1,197,090 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $181,141,669 | 1,118,780 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $81,943,404 | 1,021,038 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $46,911,404 | 862,342 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,739,747 | 741,436 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,775,562 | 655,355 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,228,431 | 591,041 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||